These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 3231038)
1. [Biguanides in oral antidiabetic therapy: indications and limitations]. Gregorio F; Filipponi P Medicina (Firenze); 1988; 8(3):262-8. PubMed ID: 3231038 [No Abstract] [Full Text] [Related]
2. [Biguanides: reasons for withdrawal of drugs and remaining indications]. Bolzano K Acta Med Austriaca; 1978; 5(3):85-8. PubMed ID: 752219 [TBL] [Abstract][Full Text] [Related]
3. [Effect of biguanide therapy on lactate metabolism during graded submaximal ergometric testing]. Pilger E; Schmid P; Goebel R Acta Med Austriaca; 1978; 5(3):91-5. PubMed ID: 752221 [TBL] [Abstract][Full Text] [Related]
4. [Blood lactate and biguanide therapy: comparison between phenformin, metformin and buformin in 408 senile diabetics]. Bruneder H; Klein HJ Acta Med Austriaca; 1978; 5(3):88-90. PubMed ID: 752220 [TBL] [Abstract][Full Text] [Related]
5. [On the clinical use of biguanides]. Haese E Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164 [No Abstract] [Full Text] [Related]
6. [Indications and contraindications to the diabetes mellitus therapy by biguanide derivatives in the light of the metabolic and epidemiologic studies (author's transl)]. Tatoń J; Kowalik-Borówka E Przegl Lek; 1979; 36(7):553-7. PubMed ID: 504704 [No Abstract] [Full Text] [Related]
8. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus. Fövényi J Ther Hung; 1971; 19(2):43-8. PubMed ID: 5172874 [No Abstract] [Full Text] [Related]
9. Biguanides. Nattrass M; Alberti KG Diabetologia; 1978 Feb; 14(2):71-4. PubMed ID: 631459 [No Abstract] [Full Text] [Related]
10. [The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)]. Irsigler K; Kritz H; Regal H; Foltin E Wien Klin Wochenschr; 1978 May; 90(10):332-7. PubMed ID: 654296 [TBL] [Abstract][Full Text] [Related]
11. [Guidelines of the Swiss Diabetic Association concerning oral antidiabetic agents]. Pernet A; Bäbler M; Ganz K Schweiz Rundsch Med Prax; 1986 May; 75(21):626-8. PubMed ID: 3726361 [No Abstract] [Full Text] [Related]
12. [Treatment of diabetes mellitus with oral antidiabetics]. Froesch ER Schweiz Med Wochenschr; 1976 Nov; 106(48):1665-7. PubMed ID: 827809 [No Abstract] [Full Text] [Related]
13. Oral hypoglycemic agents in type II diabetes mellitus. Lubbos H; Miller JL; Rose LI Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707 [TBL] [Abstract][Full Text] [Related]
15. [Therapeutic utility of biguanides in the treatment of NIDDM]. Fujimoto S Nihon Rinsho; 1999 Mar; 57(3):657-62. PubMed ID: 10199150 [TBL] [Abstract][Full Text] [Related]
16. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer. Prescrire Int; 2009 Jun; 18(101):115. PubMed ID: 19637427 [No Abstract] [Full Text] [Related]
17. [Oral antidiabetic agents: what are the choices?]. Crausaz FM Rev Med Suisse Romande; 1991 Aug; 111(8):701-5. PubMed ID: 1925244 [No Abstract] [Full Text] [Related]
18. [Semi-automatic determination of blood lactate during hypoglycemic treatment with biguanides]. Gelo Signorino R; Castellazzi R; Gamba S; Grassi G; Zanno C; Bruni B Ann Osp Maria Vittoria Torino; 1979; 22(1-6):18-37. PubMed ID: 122229 [TBL] [Abstract][Full Text] [Related]
19. [Possibilities and limits of oral diabetes therapy]. Bruneder H Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376 [No Abstract] [Full Text] [Related]
20. Clinical experience with the oral administration of the antidiabetic buformin. Sieberová R Rev Czech Med; 1971; 17(4):219-21. PubMed ID: 5122079 [No Abstract] [Full Text] [Related] [Next] [New Search]